Ablative Solutions
Ablative Solutions, Inc is pioneering new approaches for the treatment of hypertension.
$77M Series B+ ·
Led by BioStar Capital · Source: startupintros.com
Total raised: $159.3M across 3 sourced rounds
All 4 rounds ↓Signals
Ablative Solutions | 377 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $77M | startupintros.com | ||
| Series B+ | $77M | startupintros.com | ||
| Series B+ | undisclosed | finsmes.com | ||
| Series A | $5.3M | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
DF
David Fischell FounderTF
Tim Fischell FounderKR
Kate Rumrill President and CEO- DKDarrin Kent VP R&D and Operations
KC
Kristine Canavan VP, Regulatory AffairsLM
Lisa Mastromattei VP Finance & Administration- SCSonia Charrier VP, Quality
- TMThomas Moore VP, Market Development
Investors
BBioStar Capitallead investor
CCKM Capital Partners
GGilde Healthcarelead investor
IInvus Opportunitieslead investor
MMichigan Accelerator Fund Ilead investor
Companies like Ablative Solutions
BBiophy$4.5M · Nov 2023FFoRx Therapeutics$50M Series A · Dec 2025
AA2 Biotherapeutics$80M Series B+ · Jan 2025
CCitryll$92.5M Series B+ · Dec 2024
RResolution TherapeuticsSeries B+ · Oct 2024
GGutCRINESeed · Jun 2023
Other companies backed by BioStar Capital
MMMI$125M Series B+ · Oct 2026
VVersa VascularSeries B+ · Aug 2026
AAmplitude Vascular SystemsSeries B+ · Feb 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ablative-solutions (get a free API key).